Track topics on Twitter Track topics that are important to you
Parc ScientifiqueGeorges Besse
Phone: 33 (0)466 048 666
Fax: 33 (0)466 048 667
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on IT, IBM, SABR, and SYNT which can Read more...
A wide range of drugs and biochemical probes - everything from antibiotics to Alzheimer's disease biomarkers - rely on natural or synthetic compounds that aid a reaction by adding carbohydrates. It's ...
Synt:em is a private French biopharmaceutical company that is focused on the discovery and development of novel drugs that address unmet medical needs in cancer, pain management and diseases of the C...
We have published hundreds of SYNT:EM news stories on BioPortfolio along with dozens of SYNT:EM Clinical Trials and PubMed Articles about SYNT:EM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SYNT:EM Companies in our database. You can also find out about relevant SYNT:EM Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...